Topic: COVID-19

The meeting came a day after US' top public health expert Fauci termed India's Covid situation very desperate and suggested the govt marshal all its resources, including armed forces.

None of the 6 ventilators given last year from PM Cares fund is operational. Even before Covid, Buxar was dependent on Varanasi & Patna for treatments that required ventilator support.

On Chinese platforms Sina Weibo and Baidu, official accounts have posted messages mocking scenes of funeral pyres at India's cremation sites.

RBI Governor Shaktikanta Das says second Covid wave is not insurmountable, immediate priority is to protect lives and livelihoods, central bank will remain proactive.

Doctors on the ground in Shahjahanpur say residents of the village are reluctant to get tested, though residents deny this. Local authorities admit to delayed test reports.

The high court also ordered probe into news reports circulating on social media regarding death of Covid patients due to lack of oxygen in Lucknow and Meerut districts.

Indian Commercial Pilots Association had demanded vaccination camps across the country for the flying crew on a priority basis amid the second wave of the pandemic.

It’s good that the Char Dham Yatra has been suspended. Vaishno Devi pilgrimage must also be called off. The gods will understand.

New Delhi: Hyderabad-based drug maker Hetero has submitted an application to start clinical trials and manufacture tocilizumab, a key drug being used in treatment of Covid patients in India, ThePrint learnt. While India is struggling with a devastating surge in Covid cases, it is also facing a shortage of tocilizumab, currently being used to treat critically ill Covid patients. Last week, the company submitted the application to conduct clinical trials to the country’s apex drug regulatory authority, the Central Drugs Standard Control Organisation (CDSCO), which functions under the Ministry of Health and Family Welfare. “We have received the application of Hetero to start clinical trials and production of the drug in India,” said a senior government official from the Ministry of Health, who did not wish to be named. Confirming this, a spokesperson of Hetero told ThePrint: “It is true that we have asked for the approval of the clinical trial and manufacturing of...

Experts say these superspreader events have been the main reason behind the surge in numbers during the ongoing second wave of the pandemic.